Senseonics (SENS) Posts Earnings Results, Beats Estimates By $0.01 EPS

Senseonics (NYSEAMERICAN:SENS) announced its quarterly earnings data on Tuesday. The company reported ($0.12) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.13) by $0.01, reports. The business had revenue of $2.90 million during the quarter, compared to analyst estimates of $2.95 million. Senseonics had a negative net margin of 828.76% and a negative return on equity of 406.72%. The business’s quarterly revenue was up 866.7% compared to the same quarter last year.

Shares of Senseonics (NYSEAMERICAN SENS) traded up $0.15 on Wednesday, hitting $3.22. 518,694 shares of the stock were exchanged, compared to its average volume of 491,711. The firm has a market capitalization of $413.30 and a price-to-earnings ratio of -6.14. The company has a debt-to-equity ratio of 0.76, a current ratio of 2.93 and a quick ratio of 2.81. Senseonics has a 1-year low of $1.26 and a 1-year high of $3.67.

Separately, Canaccord Genuity reaffirmed a “buy” rating on shares of Senseonics in a research report on Friday, March 2nd.

WARNING: This news story was originally published by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this news story on another site, it was illegally copied and reposted in violation of US & international copyright and trademark law. The correct version of this news story can be accessed at

About Senseonics

Senseonics Holdings, Inc is a medical technology company. The Company focuses on the design, development and commercialization of glucose monitoring systems. The Company operates through glucose monitoring systems segment. It offers a continuous glucose monitoring (CGM) system, Eversense, which is designed an implantable CGM system designed to continually measure glucose levels in people with diabetes.

Earnings History for Senseonics (NYSEAMERICAN:SENS)

Receive News & Ratings for Senseonics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics and related companies with's FREE daily email newsletter.

Leave a Reply